Peter Lommer K.
- Country
- Denmark
- Department
- Department of Endocrinologogy and Nephroloogy
Research Overview
- Repurposing colchicine for reduction of residual inflammatory risk in type 1 diabetes (REC1TE): a randomized, double-blind, placebo-controlled, investigator-initiated trial
- Efficacy of Denosumab in Treating Acute Charcot Neuroarthropathy in Diabetic Patients: A Multicenter, Double-Blind, Randomized, Placebo-Controlled Trial
Data & Insights
Has run more than one trial at 2 of 9 partner sites.
Specializations
Diabetes Management
This investigator specializes in advanced therapeutic approaches for Type 1 diabetes and its complex complications, with particular attention to inflammatory markers and metabolic control.
- Inflammatory risk management in diabetes
- Biomarker assessment and monitoring
- Novel therapeutic interventions
The research focuses on exploring innovative treatment strategies to address residual inflammation in diabetic conditions.
Diabetic Complications
The investigator has developed expertise in treating Charcot neuroarthropathy, a severe complication affecting diabetic patients, with emphasis on bone health management and preventive care.
- Acute Charcot foot treatment
- Bone metabolism disorders
- Diabetes-related foot complications
Their work encompasses innovative approaches to managing acute manifestations of diabetic foot complications.
Therapeutic Innovation
The investigator explores targeted therapeutic approaches for complex diabetic conditions, incorporating both established and novel treatment modalities.
- Advanced treatment protocols
- Clinical outcomes assessment
- Therapeutic drug applications
Their research integrates multiple therapeutic strategies to address various aspects of diabetic disease management.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.